Erratum: Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated With Alopecia Areata in the United States (JAMA Dermatology (2013) 149:7 (789-794) DOI: 10.1001/jamadermatol.2013.3049));Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States

JAMA Dermatology

Volumn 149, Issue 7, 2013, Pages 789-794

  Huang, Kathie P ^a,b   Mullangi, Samyukta ^b   Guo, Ye ^a,b   Qureshi, Abrar A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ALOPECIA AREATA; AMERICAN INDIAN; ANEMIA; ANXIETY DISORDER; ARTICLE; ASIAN; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; CAUCASIAN; CLINICAL EVALUATION; COMORBIDITY; CONTACT DERMATITIS; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; ECZEMA; ENTERITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HISPANIC; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGRO; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; THYROID DISEASE; UNITED STATES; VITILIGO;

EID: 84880603463     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.920     Document Type: Erratum

References (40)

1. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update, part I: clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-190.
2. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366(16):1515-1525.
3. Barahmani N, Schabath MB, Duvic M; National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581-591.
4. Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol. 1969;81(12):877-881.
5. Du Vivier A, Munro DD. Alopecia areata, autoimmunity, and Down's syndrome. Br Med J. 1975;1(5951):191-192.
6. Grandolfo M, Biscazzi AM, Pipoli M. Alopecia areata and autoimmunity. G Ital Dermatol Venereol. 2008;143(5):277-281.
7. Gu SQ, Ros AM, von Stedingk LV, Thyresson N, Wasserman J. T cell subpopulations and their functions in vitro: a study in patients with alopecia areata and alopecia universalis. Int Arch Allergy Appl Immunol. 1981;66(2):208-217.
8. Hann SK, Koo SW, Kim JB, Park YK. Detection of antibodies to human melanoma cells in vitiligo and alopecia areata by Western blot analysis. J Dermatol. 1996;23(2):100-103.
9. Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc. 2004;9(1):73-78.
10. Kalish RS. Clues from alopecia areata on the role of neuropeptides in the initiation of autoimmunity. J Invest Dermatol. 2007;127(6): 1289-1291.
11. Kalish RS, Gilhar A. Alopecia areata: autoimmunity-the evidence is compelling. J Investig Dermatol Symp Proc. 2003;8(2):164-167.
12. Katsinelos P, Kountouras J, Paroutoglou G, Zavos C. Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links? Dig Dis Sci. 2007;52(5):1288-1292.
13. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr. 2009;21(4):475-480.
14. Lutz G, Bauer R. Autoimmunity in alopecia areata: an assessment in 100 patients. Hautarzt. 1988;39(1):5-11.
15. Rosenstein ED, Warshauer BL. Alopecia areata and autoimmunity. J Am Acad Dermatol. 2010;62(6):1065.
16. Serarslan G, Savas N, Yenin JZ. Is atopy and autoimmunity more prevalent in patients with alopecia areata? a comparative study. J Eur Acad Dermatol Venereol. 2012;26(6):720-723.
17. Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol. 2008;53(2):70-74.
18. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46(2):121-131.
19. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update, II: treatment. J Am Acad Dermatol. 2010;62(2):191-204.
20. Assouly P. Alopecia areata: update on therapy. Ann Dermatol Venereol. 2002;129(5, pt 2):831-836.
21. Galán-Gutiérrez M, Rodríguez-Bujaldón A, Moreno-Giménez JC. Update on the treatment of alopecia areata. Actas Dermosifiliogr. 2009;100(4): 266-276.
22. Shapiro J. Alopecia areata: update on therapy. Dermatol Clin. 1993;11(1):35-46.
23. Shapiro J. Dermatologic therapy: alopecia areata update. Dermatol Ther. 2011;24(3):301.
24. Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J Investig Dermatol Symp Proc. 2003;8(2):219-221.
25. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M; National Alopecia Areata Registry. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010;62(3):525-527.
26. Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. Semin Cutan Med Surg. 2010;29(1):10-15.
27. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009;122(12): 1150.e1-1150.e9.
28. Dominguez PL, Han J, Li T, Ascherio A, Qureshi AA. Depression and the risk of psoriasis in US women [published online October 3, 2012]. J Eur Acad Dermatol Venereol. doi:10.1111/j.1468- 3083.2012.04703.x.
29. Li W, Han J, Hu FB, Curhan GC, Qureshi AA. Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. J Invest Dermatol. 2012;132(2): 291-298.
30. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20(9):1055- 1060.
31. Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949-956.
32. Ahmed AM, Barahmani N, Duvic M; National Alopecia Areata Registry. Familial alopecia areata and chronic thrombocytopenia. J Am Acad Dermatol. 2008;58(5)(suppl 1):S75-S77.
33. Kurtev A, Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol. 2005;44(6):457-461.
34. Ikeda T. A new classification of alopecia areata. Dermatologica. 1965;131(6):421-445.
35. Betz RC, Pforr J, Flaquer A, et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol. 2007;127(11):2539-2543.
36. Colón EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry. 1991;32(3):245-251.
37. Bashir K, Dar NR, Rao SU. Depression in adult dermatology outpatients. J Coll Physicians Surg Pak. 2010;20(12):811-813.
38. Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008;47(11):1118-1120.
39. Paus R, Arck P. Neuroendocrine perspectives in alopecia areata: does stress play a role? J Invest Dermatol. 2009;129(6):1324-1326.
40. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol. 2003;42(6): 434-437.